- Home
- XPEL vs LENZ Comparison
XPEL vs LENZ Comparison
Compare XPEL & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEL
- LENZ
- Stock Information
- Founded
- XPEL 1999
- LENZ 2019
- Country
- XPEL United States
- LENZ United States
- Employees
- XPEL N/A
- LENZ N/A
- Industry
- XPEL Industrial Specialties
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- XPEL Industrials
- LENZ Health Care
- Exchange
- XPEL Nasdaq
- LENZ Nasdaq
- Market Cap
- XPEL 984.3M
- LENZ 1.1B
- IPO Year
- XPEL N/A
- LENZ 2021
- Fundamental
- Price
- XPEL $33.29
- LENZ $42.23
- Analyst Decision
- XPEL
- LENZ Strong Buy
- Analyst Count
- XPEL 0
- LENZ 4
- Target Price
- XPEL N/A
- LENZ $49.75
- AVG Volume (30 Days)
- XPEL 163.1K
- LENZ 411.0K
- Earning Date
- XPEL 11-06-2025
- LENZ 11-05-2025
- Dividend Yield
- XPEL N/A
- LENZ N/A
- EPS Growth
- XPEL 2.75
- LENZ N/A
- EPS
- XPEL 1.76
- LENZ N/A
- Revenue
- XPEL $448,897,000.00
- LENZ $5,000,000.00
- Revenue This Year
- XPEL $12.54
- LENZ N/A
- Revenue Next Year
- XPEL $10.52
- LENZ $258.37
- P/E Ratio
- XPEL $19.00
- LENZ N/A
- Revenue Growth
- XPEL 9.96
- LENZ N/A
- 52 Week Low
- XPEL $24.25
- LENZ $16.54
- 52 Week High
- XPEL $47.23
- LENZ $42.77
- Technical
- Relative Strength Index (RSI)
- XPEL 38.11
- LENZ 61.30
- Support Level
- XPEL $33.00
- LENZ $39.62
- Resistance Level
- XPEL $37.76
- LENZ $41.80
- Average True Range (ATR)
- XPEL 1.62
- LENZ 1.94
- MACD
- XPEL -0.47
- LENZ -0.04
- Stochastic Oscillator
- XPEL 4.67
- LENZ 90.05
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.